← Insider buys
APRE

Aprea Therapeutics, Inc. · Healthcare

5Am Ventures Iv, L.P. sold $7.0M of Aprea Therapeutics, Inc.

10% owner

Sold$7,044,412
$28.75Price
245,000Shares
−37%Stake

What APRE did after the filing

Prices for APRE after this filing aren't in yet.

Traded Thu, Jun 11. Filed Mon, Jun 15, 5:12 PM ET, after the close. Not investment advice.